IL13 and asthma: Inflammatory mediator release including Th2 cytokines (IL-4 and IL-13), and lipid eicosanoids (prostaglandins, leukotrienes and lipoxins), from eosinophils also contribute to the clinical symptoms of asthma through their potent effects on airway vascular tissue and smooth muscle reactivity [84].